Skip to main content
Premium Trial:

Request an Annual Quote

Syngenta Taps GenomeQuest for Ag-Bio Data-Management Needs

Premium

Syngenta will use GenomeQuest's sequence data-management platform to analyze plant, insect, and microbial genomes and transcriptomes generated on next-generation sequencing platforms, GenomeQuest said this week.

In addition, GenomeQuest said that Syngenta's NGS sequences and annotations will be processed and stored in its data center, a hardware and software architecture developed by GenomeQuest and SGI to support the company's software-as-a-service delivery model.

GenomeQuest said that Syngenta relies on a "mixed-model" NGS platform that combines internal hardware "with external capacity provided by collaboration with several global organizations."

Syngenta plans to use GenomeQuest's application programming interface to customize the platform, host existing research applications, create new applications, and connect to enterprise and partner systems.

Syngenta will use GenomeQuest's platform to identify genes and variants that improve plant yields and increase plant protection. Syngenta has collected sequence data from thousands of individual samples including 25 plant species and numerous insects and microbes.

This announcement comes a week after GenomeQuest announced that it had formed a two-year partnership with Harvard University's Beth Israel Deaconess Medical Center to develop whole-genome analysis applications for personalized healthcare. (BI 10/22/2010)

In a recent interview with BioInform, Ron Resnick, GenomeQuest's acting CEO, said that the agricultural biotech sector is a promising short-term market that would be a "major source of revenue" for the firm (BI 09/17/2010).

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.